O’Brien. Start Free Trial and get instant access to Tallulah True Bluebird Thurman-O’Brien's email address, Agent, Manager ...

In the closing of the recent trading day, Blue Bird (BLBD) stood at $32.93, denoting a +1.73% change from the preceding trading day.

Bluebird Bio Inc. (NASDAQ: BLUE) shares are trading higher Monday after the company received an unsolicited takeover offer from Ayrmid Ltd.

Bluebird bio on Friday received a new buyout offer that surpasses a take-private bid the pioneering gene therapy developer received last month. In a short statement, Bluebird confirmed Ayrmid Ltd., ...

Bluebird Bio reviews an unsolicited $4.50 per share bid from Ayrmid after agreeing to a $3.00 per share buyout with Carlyle and SK Capital.

December 14, 2023 Bluebird signs pact with insurer for sickle cell gene therapy Bluebird bio said on Thursday a large insurer had agreed to cover its newly approved sickle cell disease gene ...

Donald Campbell CBE tried for the 300mph World Water Speed Record on Coniston Water in Bluebird K7 before it ended in tragedy ...

Gene therapy maker bluebird bio said on Friday it had received a non-binding offer from peer Ayrmid for up to $110.5 million, sending its shares up 9.8% at $4.40 in extended trading.

There’s probably no better or beautiful sign of spring in the bird world than the arrival of the Eastern Bluebird – our New ...

US gene therapy company bluebird bio (Nasdaq: BLUE) has confirmed receipt of an unsolicited non-binding written proposal from ...

Highbridge Capital & Ayrmid offer $45M to buy bluebird bio, topping Carlyle/SK Capital's $29M bid, with additional payment ...